Viridian Therapeutics, Inc.VRDNNASDAQ
Loading
Total Assets Over TimeExpanding
Percentile Rank100
3Y CAGR+27.4%
5Y CAGR+46.9%
Year-over-Year Change
Total value of everything the company owns
3Y CAGR
+27.4%/yr
vs +60.1%/yr prior
5Y CAGR
+46.9%/yr
Recent deceleration
Acceleration
-32.8pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
6.9x
Strong expansion
Streak
6 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $899.42M | +21.1% |
| 2024 | $742.40M | +51.4% |
| 2023 | $490.42M | +12.7% |
| 2022 | $435.09M | +113.6% |
| 2021 | $203.71M | +55.2% |
| 2020 | $131.25M | +333.7% |
| 2019 | $30.26M | -54.3% |
| 2018 | $66.15M | +26.0% |
| 2017 | $52.48M | +1132.2% |
| 2016 | $4.26M | - |